IHS Chemical Week

U.S. Bill Would Fund FDA Pharma Inspections

1:33 PM MDT | March 13, 2012 | Kara Sissell

Several U.S. lawmakers have introduced a bill that would result in more resources for FDA officials to conduct inspection of overseas drug ingredient manufacturers. The terms of the Generic Drug and Biosimilar User Fee Act have been a long-standing priority for Socma, which has a bulk pharmaceutical task force working on the issue. Socma says up to 40% of U.S. pharmaceuticals and up to 80% of drug intermediates are imported.   One of the goal’s of the bipartisan bill is to reduce the amount of time that it takes FDA to approve new drugs, from...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.


Forgot your user ID or password?
Click here to have it sent to you. 

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa